Donggwang Linagliptin Tablet 5 mg
Linagliptin 5mg
Tablet · Prescription medication
Donggwang Pharmaceutical Co., Ltd.
MFDS item code 202000323 · Approved 2020.01.21
Improvement of glycemic control in patients with type 2 diabetes mellitus
This drug can be used together with diet and exercise therapy to help control blood sugar in patients with type 2 diabetes. It can also be used alone, and when there is difficulty in blood sugar control in patients with no prior diabetes treatment experience, it is administered in combination with metformin. It can be combined with metformin or sulfonylurea when blood sugar control is not satisfactory with monotherapy. Additionally, it can be used as an add-on therapy for patients who are on insulin therapy but still have insufficient blood sugar control. If blood sugar control remains difficult even after combination therapy of sulfonylurea and metformin or empagliflozin and metformin, this drug can be used in combination to enhance control. Therefore, this drug is effectively used at various stages of treatment to assist in blood sugar control.
The recommended dose of this drug is 5 mg once daily. It may be administered regardless of meals. When used in combination with insulin or an insulin secretagogue (such as a sulfonylurea), a lower dose of insulin and the insulin secretagogue may be needed to minimize the risk of hypoglycemia.
This drug should not be used in patients who have allergic reactions to the active ingredient or other components. It should also not be administered to patients with type 1 diabetes or diabetic ketoacidosis. Careful use is necessary when this drug is used with other medications such as insulin or sulfonylureas that may induce hypoglycemia due to increased risk. Experience in administering this drug to patients with heart failure is limited, so it should be used cautiously. Symptoms of acute pancreatitis may occur; therefore, if severe abdominal pain persists, discontinue use immediately and consult a doctor. A skin condition resembling bullous pemphigoid may occur, so patients should inform a doctor immediately if blisters or erosion appear on the skin. Hypoglycemic symptoms may occur during treatment; appropriate measures should be taken if symptoms arise. The use of this drug is not recommended for pregnant or breastfeeding women, especially during pregnancy as safety has not been established. Its safety and efficacy have not been sufficiently confirmed in children and adolescents, so it is not recommended for them. It can be used in elderly patients without special dose adjustments, and patients with decreased kidney or liver function can also use it without dose adjustments. In cases of overdose, non-absorbed medication should be removed from the gastrointestinal tract, and clinical symptoms should be monitored with necessary treatment. This drug must be stored out of reach of children and should not be transferred to other containers.
Hypoglycemia, hypersensitivity, angioedema, urticaria, cough, pancreatitis, constipation, oral ulcer formation, rash, blistering-like pemphigoid, severe and disabling arthralgia, rhabdomyolysis, weight gain, increased lipase, increased amylase, dyspepsia, edema, facial swelling, peripheral edema, weight loss, increased appetite, constipation, upper abdominal pain, enterocolitis, bowel obstruction, gastritis, herpes zoster, cystitis, acute pyelonephritis, bronchitis, vestibular neuronitis, sepsis, pneumonia, decreased appetite, dehydration, hyperglycemia, cerebral infarction, speech disorders, Alzheimer's dementia, chest pain, fever, facial edema, fatigue, death, chronic obstructive pulmonary disease, asthma, diabetic foot, skin lesions, liver metastasis, acute leukemia, basal cell carcinoma, non-small cell lung cancer, malignant pericardial effusion, gastric cancer, rectal cancer, pancreatic cancer, meniscus injury, pneumoconiosis, congestive heart failure, angina, acute myocardial infarction, unstable angina, cardiac arrest, diabetic retinopathy, acute kidney injury, end-stage renal disease, acute cholangitis, acute cholecystitis, cholangitis, cholelithiasis, dizziness, kidney transplant failure, anemia, nausea, diarrhea, vomiting, gastroesophageal reflux disease, gastritis, viral upper respiratory infection, upper respiratory infection, postherpetic neuralgia, drowsiness, chest discomfort, weakness, pain, nosebleed, oropharyngeal pain, voice disorders, allergic rhinitis, exertional dyspnea, wet cough, runny nose, lung mass, arthralgia, osteoporosis, arthropathy, musculoskeletal discomfort, myositis, myalgia, soft tissue mass, postmenopausal osteoporosis, rotator cuff syndrome, increased triglycerides in blood, increased urine albumin/creatinine ratio, positive urine leukocytes, decreased hemoglobin, increased potassium in blood, increased creatinine in blood, increased creatine phosphokinase in blood, increased ALT, increased AST, androgenetic alopecia, hyperhidrosis, hair loss, dermatitis, anxiety, affective disorders, insomnia, depression, contusion, bone contusion, concussion, fracture of the bone, hand fracture, laceration, palpitations, dry eyes, glaucoma, cataract, eye discomfort, allergic conjunctivitis, polyuria, proteinuria, stress urinary incontinence, hematuria, hypotension, flushing, fatty liver, hearing loss, erectile dysfunction, goiter, benign prostatic hyperplasia
Not everyone experiences these, and they can vary from person to person.
This drug should be stored in a closed container to protect it from air and moisture, preferably at room temperature between 1 to 30 degrees Celsius. Proper storage will help maintain the drug's efficacy over time.
Bright red film-coated round tablets
30 tablets/box [(10 tablets/PTP) x 3], 30 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Linagliptin 5mg
Tablet · Prescription medication
Donggwang Pharmaceutical Co., Ltd.

Linagliptin 5mg
Tablet · Prescription medication
Boehringer Ingelheim Korea Co., Ltd.

Linagliptin 5mg
Tablet · Prescription medication
International Pharmaceutical Co., Ltd.

Linagliptin 5mg
Tablet · Prescription medication
Aju Pharmaceuticals Co., Ltd.

Linagliptin 5mg
Tablet · Prescription medication
Albozen Korea Co., Ltd.
Linagliptin 5mg
Tablet · Prescription medication
Anguk Pharmaceutical Co., Ltd.

Linagliptin 5mg
Tablet · Prescription medication
Hana Pharmaceutical Co., Ltd.

Linagliptin 5mg
Tablet · Prescription medication
Kyungdong Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.